Advertisement

Current Environmental Health Reports

, Volume 1, Issue 2, pp 132–147 | Cite as

The Effects of Arsenic Exposure on Neurological and Cognitive Dysfunction in Human and Rodent Studies: A Review

  • Christina R. Tyler
  • Andrea M. AllanEmail author
Open Access
Metals and Health (A Barchowsky, Section Editor)

Abstract

Arsenic toxicity is a worldwide health concern as several millions of people are exposed to this toxicant via drinking water, and exposure affects almost every organ system in the body including the brain. Recent studies have shown that even low concentrations of arsenic impair neurological function, particularly in children. This review will focus on the current epidemiological evidence of arsenic neurotoxicity in children and adults, with emphasis on cognitive dysfunction, including learning and memory deficits and mood disorders. We provide a cohesive synthesis of the animal studies that have focused on neural mechanisms of dysfunction after arsenic exposure including altered epigenetics; hippocampal function; glucocorticoid and hypothalamus-pituitary-adrenal axis (HPA) pathway signaling; glutamatergic, cholinergic and monoaminergic signaling; adult neurogenesis; and increased Alzheimer’s-associated pathologies. Finally, we briefly discuss new studies focusing on therapeutic strategies to combat arsenic toxicity including the use of selenium and zinc.

Keywords

Arsenic Exposure Arsenite Arsenate Teratogen Development Neurotoxicity Cognition Alzheimer’s disease Cholinergic Monoaminergic Glutamatergic Neurogenesis Children Adult HPA Cortisol Glucocorticoid receptor IQ Neurological deficits Mood disorders Epigenetics Histone modifications DNA methylation Depression Anxiety Lead 

Introduction

Arsenic is ranked first among toxicants posing a significant potential threat to human health based on known or suspected toxicity [1]. This naturally occurring metalloid is a known poison, a co-carcinogen, and in lower concentrations has been shown to increase susceptibility to cognitive dysfunction [2]. Currently, the permitted concentration of arsenic in water is 10 μg/L (10 ppb). Yet, an estimated 100 million people worldwide are exposed to excessive amounts of arsenic via drinking water (in the ppm range). Many of these individuals obtain drinking water from unregulated sources (wells) or live in regions where arsenic levels are high, as in Bangladesh. As arsenic leaches from rock formations into water sources as the water table recedes, exposure to high amounts of arsenic will continue to persist as the demand for clean water increases. This phenomenon particularly affects the Western region of the United States, where it is estimated that certain areas contain up to 3100 μg/L arsenic (31 ppm) in drinking water, on par with levels reported in Taiwan and China [2]. While the World Health Organization (WHO) and the Environmental Protection Agency (EPA) regulate water sources of arsenic, lack of strict regulations on food, beverages, and air quality can lead to increased arsenic exposure [3]. Ingestion of arsenic activates metabolic pathways for excretion, resulting in a number of metabolites, some of which are more potent and toxic than the originally ingested inorganic form of arsenic (iAs), including mono- and dimethylated arsenicals [4, 5, 6, 7, 8].

All forms of arsenic, including inorganic and methylated arsenicals, accumulate in many parts of the brain, with the highest accumulation in the pituitary [9]. Additionally, arsenic is a well-established teratogen that crosses the placenta during development, and in high concentrations, induces growth delays and neural tube defects [10, 11, 12]. Epidemiological studies reviewed in this paper have investigated the neurological and cognitive effects of arsenic on children and adults. Evidence presented suggests that chronic ingestion of arsenic alters a number of intelligence measures and induces learning deficits and mood disorders like depression. Information on dose, concentration, extent, and method of exposure of arsenic will be given for each study. We provide a detailed review of the mechanisms involved in arsenic-induced toxicity in the brain. These include altered glucocorticoid signaling, cholinergic and monoaminergic signaling, adult neurogenesis and other forms of synaptic plasticity, and behavioral deficits including learning, memory, and locomotion. The last section of this review discusses new studies on therapeutics used in rodent models that may eventually be useful for remedying arsenic-induced neurological deficits in human populations.

Epidemiological Studies

Children Exposed to Arsenic: Cognitive Assessments

Over the past two decades, various epidemiological reports have shown that arsenic exposure may alter cognitive function, particularly learning and memory during childhood. A recently published meta-analysis focused on the impact of arsenic exposure on intelligence measured by IQ tests [13••]. Researchers concluded that arsenic exposure was associated with a 0.4 decrease in IQ in exposed children [13••]. This appears to be a minor decrease in IQ, but these changes could have cumulative effects later on in life. For our purposes, we will provide a synopsis of epidemiological studies focusing on other neurobehavioral measures in children.

Several studies have shown a relationship between low arsenic exposure (in the parts-per-billion range) and children’s intellectual performance on a battery of cognitive tests that cover a number of skills and processes. For example, a 2007 study found a significant association between urinary arsenic concentrations greater than 50 μg/L and poor scores on tests measuring visual-spatial reasoning, language and vocabulary, memory, intelligence, and math skills in 6-8 year old (y.o.) children from Mexico [14]. It should be noted that researchers found a sex-specific effect of arsenic: males performed more poorly on all assessments compared to females. However, males had higher arsenic concentrations (mean 11.85 μg/L) in their urine, which could account for these differences. In another cohort of children in Mexico (6-7 y.o. with 55 μg/L urinary arsenic), researchers reported poorer scores in arsenic-exposed children on measures of language and vocabulary and a modest association with hyperactive behavior using the attention deficit hyperactive disorder (ADHD) index [15]. In India, a cross sectional study on 351 children (5-15 y.o.) exposed to an average of 147 μg/L arsenic in water throughout development and childhood found an association between arsenic exposure and poor performance in several measures focusing on vocabulary, math skills, memory, and overall cognition; however, confidence intervals and the age range of participants in this study were broad [16]. When accounting for age range and other covariates (education, levels of arsenic, socioeconomic status), there was a dose-dependent relationship between arsenic levels in water and poor performance scores on intelligence measures [17]: children exposed to >50 μg/L arsenic had poorer intellectual performance than those exposed to <5.5 μg/L arsenic [17]. While low exposures to arsenic (< 2 μg/L) resulted in no measurable effects on IQ, moderate exposures (142 μg/L and 190 μg/L) resulted in decreases of 5 and 10 IQ points, respectively [18]. These findings, along with other studies (Table 1) support the association between moderate arsenic exposure and deficits in cognitive skills in children exposed during development.
Table 1

Impacts of arsenic on cognition in children and adults

Cognitive assessment

Exposure

Age

Finding

Reference

Intelligence (IQ)

Low and High

Children

↓verbal IQ

↓total IQ

Calderon et al. 2001 [42]

Medium

Children

↓total IQ

Rosado et al. 2007 [14]

Low and High

Children (5-15 y.o.)

↓total IQ

Von Ehrenstein et al. 2007 [16]

Low

Children (9-10 y.o.)

↓total IQ

Wasserman et al. 2004 [17]

Low

Children (6 y.o. and 10 y.o.)

↓total IQ

Wasserman et al. 2007 [30]

Low and Medium

Children (5 y.o.)

↓total IQ (females)

↓verbal IQ (females)

Hamandani et al. 2011 [26•]

Cognitive skills (reading, writing, vocabulary, math)

Medium

Children (6-7 y.o.)

↓capacity in figure design, vocabulary, letter sequencing

Rosado et al. 2007 [14]

Medium

Children (6-7 y.o.)

↓capacity in vocabulary

Roy et al. 2011 [15]

Low and High

Children (5-15 y.o.)

↓capacity in vocabulary, language

Von Ehrenstein et al. 2007 [16]

Low

Adults

↓capacity in executive function, mental acuity, verbal skills

O’Bryant et al. 2011 [43••]

Visual perception

Medium

Children (6-7 y.o.)

↓capacity in visual search

Rosado et al. 2007 [14]

Low and High

Children (5-15 y.o.)

↓capacity in picture completion, object assembly

Von Ehrenstein et al. 2007 [16]

Mental health

Medium

Children

↑risk for ADHD

Roy et al. 2011 [15]

Low

Adults

↑incidence of depression

Zierold et al. 2004 [53]

Medium

Adults

↑symptoms of anxiety

Dang et al. 2008 [50], Dang et al. 2009

Low → High

Adults

↓quality of life and mental health

Syed et al. 2012 [47]

High

Adults

↑symptoms of altered mental health

Fujino et al. 2004 [51]

Low → High

Adults

↑insomnia ↓general health

Guo et al. 2007 [49]

Low → High

Adults

↑risk of psychiatric disorder, depression, anxiety

Sen et al. 2012 [52]

Exposure

Low: less than 50 μg/L (ppb) urinary arsenic or water arsenic

Medium: between 50 μg/L (ppb) and 100 μg/L (ppb) urinary or water arsenic

High: more than 100 μg/L (ppb) urinary arsenic or water arsenic

As mentioned above, a common finding in these studies seems to be the differential effect of arsenic among young males and females; while this has not received much attention [19], some research suggests that arsenic impedes growth and development in young females more than males, which in turn could impact cognitive function [20]. In studies where urinary arsenic levels between males and females are comparable, females aged 5-15 y.o. had a larger negative response to arsenic [21]. Overall, in addition to poor cognitive assessments, children exposed to arsenic in well water also have poor development scores (i.e., height), which correlates with lower intellectual function; this effect may be more pronounced in females than males [22].

In Utero and Cumulative Exposure to Arsenic

Most epidemiological studies focusing on the effects of arsenic exposure in children, with exposures occurring across several years, have reported impaired cognition regardless of the concentration of arsenic. Conversely, studies evaluating the impact of arsenic exposure only in utero fail to show consistent cognitive deficits. Analysis of arsenic in cord blood one day after birth (1.33 μg/L) and subsequent behavioral assessment (Brazelton Scale) showed an inverse correlation between arsenic levels and neurodevelopment in newborns in Nepal [23]. Yet, an early-life longitudinal study of pre- and postnatal arsenic exposure reported no significant correlations between maternal or child arsenic levels and psychomotor and mental development index assessments, behavior, or the maternal report of language acquisition in 18 month old children [24]. Additionally, infants born to mothers with urinary arsenic levels of 80 μg/L during pregnancy showed no cognitive impairment when accounting for age, sex, and socioeconomic status [25]. Measurable impaired cognition becomes evident later in life: a Bangladesh study from the same group demonstrated a correlation between the mother’s and child’s urinary arsenic content (80 and 51 μg/L respectively) and verbal IQ and full scale IQ but only in females at 5 years of age [26•]. Research focused on the adolescent time period of development provides more insight, suggesting that long-term cumulative exposure is more harmful for cognitive function including alterations in pattern memory, attention set shifting [27], full scale IQ, verbal IQ, and functional memory [28]. The levels of arsenic among these different cohorts of teens were highly variable, ranging from 17.8 μg/L as assessed in hair [28] to 132 and 185 μg/L arsenic in well water [27]; thus, conclusions determined from comparing these studies are limited. Additionally, data from toxin assessment in hair has been deemed somewhat insufficient to predict health outcomes as information of toxin content varies according to gender, ethnicity, and pharmacokinetics [29]. However, all groups in these studies had developmental exposure to arsenic. As with other teratogens, the timing, dose, and duration of arsenic exposure seem to determine the extent of neurological insults on children, and these insults may occur during development to produce cognitive dysfunction in adolescence or adulthood.

Chronic moderate exposure to arsenic, more so than high acute exposure, may induce greater harm on intellectual function in children. Several investigations by Wasserman and colleagues showed that the relationship between arsenic exposure and cognition in children might be age dependent. In a study of arsenic-exposed children aged 6 y.o., researchers found a negative association between arsenic and performance on the Wechsler Preschool and Primary Scale of Intelligence (WPPSI-III) [30]; yet this association was not as substantive as the inverse association observed in 10 y.o. children, who had longer arsenic exposure [17]. Both cohorts of primary school children showed reduced intellectual function and performance, reduced processing speed, and lower full-scale raw scores with arsenic exposures between 5-50 μg/L during development. Yet, the chronic nature of the exposure combined with the concentration of arsenic had the most adverse effect on cognitive ability and neurological functioning in children.

Factors Comorbid with Arsenic Exposure

One difficulty in drawing conclusions of the effect of arsenic on cognitive ability is that exposure is commonly associated with other factors that could affect the outcomes of these studies (Table 2). These include exposures to a mixture of metals, low socioeconomic status, and poor nutrition.
Table 2

Factors comorbid with arsenic exposure

Exposure to arsenic impacts performance on a variety of cognitive assessments in children; however, other factors could contribute to the negative effects of arsenic.

Metal mixtures: Arsenic is not the only naturally occurring element that leaches into water sources. Other metals including lead, mercury, manganese, cadmium, and copper exist in significant quantities, particularly in well water. Thus, arsenic may not be acting alone in disrupting cognition in children; it may be the mixture of metals that is reducing intelligence and other measures of neurological function.

Socioeconomic status: Unfortunately, millions of children live in poverty all over the world; and low socioeconomic status correlates with reduced cognitive function. Children living in poor areas typically do not have access to clean water and are more likely to be exposed to high levels of arsenic.

Nutrition: Along with lower SES and exposure to metals, children exposed to arsenic typically have poor nutrition, likely due to an impoverished situation. Additionally, metabolism of arsenic can interfere with nutrient absorbance. It’s likely that arsenic exposure in combination with these other factors accounts for the cognitive deficits observed in exposed children.

Metal Mixtures

The presence of arsenic in water or the environment does not preclude the presence of other elements; in fact, it is probable that a number of metals (Pb, Mn, Cd, Hg) are comorbid in individuals with arsenic exposure in the studies provided here. Reports on developmental exposures to heavy metal mixtures suggest that combined exposure is associated with greater risk for cognitive dysfunction, including behavior and impaired neurological (CNS) development [31]. The incidence of mental retardation is highly correlated with the presence of soil metals in rural areas (As, Cu, Pb, Mn, Hg), and the probability of intellectual disability in children increases as the concentration of arsenic and lead in the soil increases [32, 33]. Yet, determining the effect of one metal in isolation is quite difficult. In several studies, the concentration of lead in blood, urine, or water (while low), still positively correlates with arsenic levels [23]. Lead in particular is a known toxicant imparting severe neurotoxic effects on the brain especially in children. Of the studies described here, only a few discuss comorbid exposures and provide information about other metal concentrations. Poor scores on cognitive assessments have been reported in children exposed to both arsenic (slightly above and below the 10 μg/L EPA standard) and manganese (500 μg/L) in well water, though the arsenic and manganese interaction was not significant [34]. Arsenic, in particular, was associated with poor working memory and lower verbal comprehension scores as previously reported in a smaller prospective study ([34]), although a significant manganese arsenic interaction was found in this study [28]. As such, further investigation on developmental neurotoxicology of arsenic in combination with other substances is warranted. The possibility that observations in epidemiological studies may be induced by comorbid factors in addition to arsenic cannot be ignored.

Socioeconomic Status

Overall, arsenic exposure is correlated with lower socioeconomic status (SES) [14], and SES correlates with lower measures on tests assessing infant development and cognition [25]. The effects of poverty and parental stress due to low SES are significant risk factors in neurodevelopment disorders [35], and parsing out these effects from arsenic exposure is quite difficult. Additionally, control cases used for epidemiological work are typically from more affluent areas without arsenic exposure. In China, cross-sectional analyses have shown that children who live in rural areas have lower IQ scores than children who live in urban areas [18, 21, 36]. Children residing in poor rural areas are more often exposed to arsenic, which may exaggerate the inverse associations found between arsenic in drinking water and IQ scores [37]. Low SES is often associated with less education, especially in developing countries; one study reported that cognitive ability in children exposed to arsenic increased as maternal education increased from primary to secondary school [16]. However, many epidemiological studies that controlled for education as a covariate still reported significant neurodevelopmental deficits imparted after arsenic exposure [23].

Nutrition

Malnutrition can have a substantial negative impact on cognitive development and performance even in the absence of arsenic or metal exposure. Children lacking proper nutrition during development, such as iron deficiency, have deficits in neurological function, including cognition [38]. Arsenic exposure is thought to increase the risk for anemia, which is a potential risk factor in blunted growth and development [39]. Current research has been focused on the possible connection between the lack of proper nutrients in diet during development (methionine, cytosine, protein, folic acid, vitamin B-12, choline, and betaine) and developmental delay [40, 41]. These nutrients are important as they boost the body’s methyl donor availability, which is critical in the metabolism of arsenic. Increased consumption of methionine, cysteine, and protein aids in the methylation of arsenic, thus enhancing excretion in individuals exposed to arsenic [41]. The ability of the developing body to metabolize arsenic and to properly execute epigenetic modifications could be impaired by the accumulation of arsenic. As such, understanding the nutritional status of the children in these studies may be critical to interpreting the effects of arsenic on cognition.

Summary of Epidemiologic Studies in Children

Overall, we can ascertain certain patterns from the epidemiological literature on the association between arsenic exposure and cognitive performance in children. A number of studies have shown that arsenic induces cognitive deficits in children, even at low concentrations. Arsenic water levels or urinary arsenic levels correlate with poorer performance and scores on intelligence measures, and verbal IQ seems to be the most affected cognitive skill. These effects persist into adolescence, such that cumulative arsenic intake may be a greater risk factor than acute intake in cognitive dysfunction. Higher concentrations of arsenic exposure can alter growth and development in children, leading to neurological deficits, and females seem to be at greater risk than males, although few studies have systematically evaluated sex differences. Potentially confounding factors in these studies include the comorbidity of other metals with arsenic exposure, the correlation between high arsenic exposure and poor socioeconomic status, and poor nutrition in children exposed to arsenic [42]. Studies on cohorts from around the world, including China, the United States, Taiwan, Bangladesh, and Mexico, have all provided significant research supporting the negative effects of arsenic on childhood development and cognitive ability.

Adults Exposed to Arsenic: Cognitive Assessments

Most epidemiological research has focused on cognition in children, and reports on the effect of arsenic exposure on adult cognition are limited. However, a series of studies has recently revealed a significant correlation between arsenic exposure and altered adult cognition, particularly for symptoms associated with Alzheimer’s disease. The FRONTIER project is an ongoing cohort study focused on a group of West Texas residents in an area that contains arsenic levels close to the EPA standard in groundwater (3-15 μg/L). Long-term and continuing chronic exposure to low levels of arsenic via drinking water significantly correlated with poorer scores in tests examining language, visual and spatial skills, and executive function, all of which indicate cognitive dysfunction [43••]. Poorer scores in global cognition, processing speed, and immediate memory were also found; these particular deficits have been associated with Alzheimer’s disease [43••, 44•]. Individuals exposed to 10.6 μg/L arsenic scored significantly worse on global cognitive assessment compared to those exposed to 6.5 μg/L arsenic, suggesting that 10 μg/L EPA standard may not be sufficient to prevent arsenic-induced cognitive deficits [44•].

There are several caveats to the FRONTIER studies. The Mini-Mental State Exam (MMSE) used for cognitive assessment has been criticized for its bias against less educated participants [45, 46]; indeed, FRONTIER participants in the 10.6 μg/L group did have less education than controls [44•]. Additionally, most of these assessments rely on verbal responses, reading, and writing, while other tests require proper auditory perception and visual acuity. The average age of the 434 FRONTIER participants in these studies was 62 years old, thus if arsenic exposure affected sensory, perception, or communication, participants may perform poorly even if no cognitive impairment exists. Finally, the arsenic concentrations in both of these FRONTIER studies were determined using the ArcGIS program based on ground water measurements made by the Texas Water Development Board; direct measurement of arsenic was not performed. However, despite these limitations, the findings presented here are important in supporting that cumulative, long-term exposure to low levels of arsenic, levels considered safe by the EPA, can impart cognitive deficits in adults.

Adults Exposed to Arsenic: Psychological Assessments

While the number of studies concerning cognitive and mental disorders after toxic exposures has increased over the past ten years, specific characterization concerning arsenic exposure and psychological health requires more epidemiological investigation. Of the studies presented here, several point to a strong correlation between arsenic toxicity and mental health status. These data are reported from all over the world including China, Bangladesh, India, and the United States. Altered cognition is typically concurrent with disturbances in mental health. As such, it is difficult to assess the validity of studies primarily focused on psychological health in arsenic-affected individuals, as the previous data we have presented shows a strong correlation between arsenic exposure and cognitive deficits. However, despite the overlap between psychological and cognitive disorders, there is substantial evidence to suggest that arsenic exposure increases the risk of impaired cognition and enhanced susceptibility for mood disorders.

Bangladesh

Bangladesh has one of the highest reported arsenic exposure rates in the world, and yet, few studies have explored the relationship between arsenic exposure and mental health. A recent cross-sectional study, published in 2012, found that patients with arsenic poisoning reported a lower quality of life and scored lower on a validated mental health index compared to individuals without arsenic exposure [47]. Arsenic poisoning has strong societal implications in Bangladesh, often resulting in individuals with arsenic exposure ostracized from the community [47]. This lack of social acceptance could contribute to the lower quality of life and mental health scores in these individuals; however, other studies on the effects of arsenic and mental health concur with those reported in this study.

China

China accounts for approximately half of the world’s arsenic production and consequently its pollution [48], and there are many regions that contain naturally high amounts of arsenic in soil deposits. Arsenic toxicity studies from China typically focus on symptoms of neurotoxicity, including loss of hearing, loss of taste, blurred vision, and tingling/numbness in the limbs [49]. Altered mental health is comorbid with these ailments, including a prevalence of insomnia [49], anxiety and depression [50], and symptoms of distress [51]. Assessments of mental health were congruent with education levels of the participants; however, as described above, exposure to metal mixtures is common, and participants exposed to metals in one study showed significantly greater urine and hair concentrations of arsenic, lead, and cadmium than control participants [50]. Additionally, water in these villages contained between 15-1860 μg/L arsenic, much higher than the Chinese Drinking Water Standard of 50 μg/L.

India

In India, over 1.5 million people have been exposed to high levels of arsenic with more than 200,000 cases of arsenicosis. Cross-sectional analysis of over 1169 arsenicosis patients between the ages of 18-65 y.o. revealed that 19 % of patients developed some type of psychiatric disorder, compared to an average 7 % prevalence of mental disorders in India [69]. Of the 19 % of patients, most were categorized as having depression and/or anxiety; yet, the prevalence of depression in India is only 3.7 %. The participants in this study were from seven different villages, 90 % of which had arsenic levels ranging from 25-900 μg/L. Most patients were males with low SES and a 25 % rate of unemployment. As noted in the studies from Bangladesh, it is difficult to determine if these patients exhibit depression due to the state of their overall health (arsenicosis) or if depression is a manifestation of the arsenic toxicity. However, in Indian society, arsenicosis patients are able to maintain their traditions, kinship, and cast relations to cope with stress of the disease [52]. Similar to observations of the general population, anxiety and depression were the most common psychiatric disorders in arsenicosis patients; however, lower SES, the diseases associated with arsenic poisoning, body image, and low self-esteem are predisposing factors of psychological issues in this population.

United States

The United States has more stringent standards of arsenic water quality than other countries (the EPA limit is 10 μg/L), yet this concentration may not be low enough as suggested by the literature on cognitive dysfunction. A 2004 cross-sectional study covered a wide range of locations in areas with low concentrations of arsenic and revealed a significant association between low arsenic exposure (2-10 μg/L) and poor mental health, particularly depression. Individuals with cumulative, long-term exposure to low concentrations of arsenic (2-10 μg/L) for more than 20 years were significantly more likely to exhibit depressive symptoms than those drinking less than 2 μg/L arsenic [53]. Interestingly, participants consuming more than 10 μg/L arsenic were also more likely to have had cardiac bypass surgery, high blood pressure, and circulatory issues than those drinking less than 2 μg/L arsenic in water [53]. Unlike studies from India, Bangladesh, and China where low levels of arsenic were not assessed, this study suggested that low exposure, under EPA limits of 10 μg/L, is associated with higher rates of adverse mental health. However, evaluating the validity of the conclusions from this study is difficult because of the lack of the critical methodological information, (e.g., participant health status, and the type and analysis of the assessment tools), which are all important in interpreting the findings.

Summary

There are several limitations to these studies, including some with small sample sizes, all with variable levels of arsenic toxicity, and arsenic-affected individuals typically living in rural areas and having lower SES. Additionally, assessment of dose-response relationships and mental health has not been determined: it would be useful to have high and moderate arsenic exposures compared in the same study. While it is difficult to disentangle the contribution of arsenic and that of general health in many of the studies conducted in countries outside of the United States, the findings presented thus far demonstrate a correlation between arsenic exposure, cognitive dysfunction, and mental health. There is clearly substantial evidence that arsenic exposure diminishes cognition and increases mood disorders in human populations. Animal and invertebrate studies have replicated many of these observations and aided in the search for the mechanisms for the adverse health impacts of arsenic.

Mechanisms of Action

It is difficult to use the epidemiological literature to identify mechanisms, as long-term exposures to arsenic are likely compounded with exposures to pollution, poor diet, and low SES. Basic science research is poised to control for these confounding factors, including extent and timing of exposure. This research has determined that arsenic imparts its toxicity on the body via a number of mechanisms. These include the depletion of methyl groups affecting epigenetic profiles, the uncoupling of oxidative phosphorylation and increased reactive oxygen species, the inhibition of thiol-containing enzymes and proteins (including the depletion of glutathione), altered signal transduction and cell proliferation, and reduced DNA repair inducing genotoxicity [1, 6]. As these mechanisms have been discussed in detail in other reviews, we cover mechanisms particularly related to the brain. These include hippocampal dysfunction; glutamatergic, glucocorticoid, cholinergic, and monoaminergic signaling; pathways associated with Alzheimer’s disease; and synaptic plasticity, particularly neurogenesis. To begin, we briefly provide results from the few studies focusing on neural epigenetic patterns altered after arsenic exposure.

Epigenetic Patterns

Arsenic accumulation and subsequent toxicity is likely mediated through multiple mechanisms of action. Of particular interest over the past few years is the impact of arsenic on the epigenome. While there have been several studies determining the impact of arsenic on epigenetic regulation in cancer cells, the liver, and other parts of the body, very few have focused the brain. Exposure to 3 and 36 ppm arsenic throughout gestation increased DNA methylation on two genes involved in neural plasticity in rat cortex and hippocampus at one month of age [54•]. Hypomethylation of these genes in both regions was observed after four months of cumulative exposure to arsenic; these animals also displayed deficits in fear memory as well, although the link between hypomethylation and memory was correlational. Since arsenic metabolism requires methyl groups derived from S-adenosylmethionine (SAM) for excretion, it is plausible that arsenic depletes SAM leading to alterations in DNA methylation. In vitro studies corroborate this assertion: 25 μM arsenic exposure for 24 hours depleted SAM concentrations, increased global DNA hypomethylation, and repressed Dnmt1 and Dnmt3a expression [55]. Epidemiological work has shown that DNA methylation is affected by arsenic in human populations as well, including umbilical cord blood, but discussion of those studies is beyond the scope of this review [56, 57, 58, 59]. We can determine that exposure to arsenic does induce epigenetic modifications to the DNA, which may result in aberrant gene expression even in the brain; however the link between DNA methylation on particular genes and cognitive deficits has yet to be elucidated.

Other epidemiological studies have determined the impact of arsenic ingestion on histone modifications. Arsenic compounds have been shown to alter gene expression and posttranslational modifications (PTM) of histones in vivo; interestingly, researchers found a differential effect of arsenic on global histone modifications among males and females [60]. In vitro assessment of low doses of arsenic on histone modifications has also been performed; however, detailed discussion of this research is beyond the scope of this review [60, 61, 62]. Rodent studies with prenatal exposure to 100 μg/L arsenic demonstrated reduced global acetylation on lysine 9 of histone 3 (H3K9ac) in the cortex and hippocampus of postnatal day (PND1) pups, which was correlated to altered learning in adulthood [63]. Exposure to 3 and 36 ppm arsenic throughout development up to four months reduced myelination (for which methylation is required) and dimethylation of arginine residues on histones [64]. This could result from the altered expression and function of epigenetic modifiers or transcription factors, as arsenic impacts zinc-finger protein expression and function [65].

These studies demonstrate that arsenic impacts DNA methylation and histone modifications and alters the enzymes responsible for regulating these modifications. The effects of arsenic on the epigenome are related to the dose and extent of arsenic exposure as seen before, but also type of histone methylation mark, gene, and sex. As such, in determining mechanisms of arsenic toxicity it will be important to control for these variables both in epidemiological and molecular studies in the future. Additionally, cumulative low-level exposure to arsenic likely occurs over generations. The literature suggests that females are differentially more affected by arsenic than males. Since females are the key source of transgenerational effects (3rd generation ova are exposed to the in utero environment), arsenic could be impacting transgenerational epigenetics, including the imprinting of genes (from both males and females). This area of research could provide an insight into the effects of arsenic on the brain and body, yet there are no published reports on arsenic exposure and transgenerational epigenetic mechanisms to date.

The Hippocampus

Studies on the mechanisms of arsenic-induced toxicity have established that arsenic alters learning and memory in behavioral assays and impacts multiple neurobiological processes including those of neurogenesis and cholinergic, glutamatergic, and monoaminergic signaling pathways. Recent work using animal models has revealed potent alterations in hippocampal function, morphology, and signaling leading to altered cognitive behavior after arsenic exposure. While the exposure paradigms and concentrations of arsenic have been highly varied, the overall conclusions have been congruent between studies (see Table 3).
Table 3

The impact of arsenic on behavioral tasks in rodent studies

Type of cognition

Task

Exposure

Finding

Reference

Learning and memory

Morris water maze (MWM)

Adult, chronic, high

↓acquisition

Luo et al. 2009 [71]

Adult, chronic, low

↓acquisition

Sharma & Sharma, 2013 [66]

Fear/cued conditioning

Adult, acute, low

↓recall

Cronican et al. 2013 [63]

8-way radial arm maze

Developmental, chronic, low

↓acquisition

Martinez-Finley et al. 2009 [67]

Y-maze; MWM

Adult, chronic, high

↓acquisition

Jing et al. 2012 [68]

Radial water maze

Adult, acute, low

↓acquisition

Cronican et al. 2013 [63]

Novel object exploration

Developmental, chronic, low

↓performance

Martinez-Finley et al. 2009 [67]

Adult, acute, low

↓performance

Cronican et al. 2013 [63]

Locomotion and motor

Startle/reflex response/ spontaneous alteration/ developmental battery tests

Developmental,

low → high

↓coordination

↑response time to completion

no change in low group

Luo et al. 2013 [86]

Developmental,

low → high

No change in either group

Gandhi et al. 2012 [87]

Rotarod

Adult, subchronic, high

↓coordination ↑ataxia

Yadav et al. 2009 [85]

Spontaneous locomotor activity

Adults, chronic, low → high

Dose-related

↑locomotion with low dose

↓locomotion with high dose

↑ locomotion females

Bardullas et al. 2009 [83]

Adults, chronic, low → high

no change in low group

↓ locomotion

Rodriguez et al. 2010 [84]

Total movement

Adult, chronic, low → high

↓ movement at high dose

Bardullas et al. 2009 [83]

Adult, subchronic, high

↓ total movement

Yadav et al. 2009 [85]

Adult, chronic, low → high

↓ total movement

Rodriguez et al. 2010 [84]

Grip strength

Adult, subchronic, high

↓ strength

Yadav et al. 2009 [85]

Exposure type:

Developmental: in utero to postnatal exposure (maternal consumption of arsenic)

Adult exposure: from weaning up to death

Exposure level:

High exposure: ppm (mg/L)

Medium exposure: above 100 ppb (μg/L)

Low exposure: below 50 ppb (μg/L)

Low → high; multiple doses examined

Exposure paradigm:

Acute: less than two weeks

Subchronic: less than one month

Chronic: more than one month

In particular, behavioral studies using hippocampal-dependent tasks, including the Morris Water Maze and fear conditioning, have corroborated epidemiological evidence of reduced cognition observed in humans with arsenic exposure. Table 3 details the behavioral paradigms and arsenic exposures used in these studies. Results from this body of literature suggest that regardless of dose, timing, or extent of exposure, arsenic induces hippocampal-dependent behavioral deficits in rodent models, suggesting impaired spatial, working, long-term, and short-term memory [63, 66, 67, 68]. Interestingly, the effect extends to nonmammalian species as arsenic exposure in Danio rerio (zebrafish) induces deficits in long-term memory as well [69]. Several of these behavioral deficits can be ameliorated with treatment; for example, sodium butyrate, a histone deacetylase inhibitor, attenuated deficits seen in the radial arm maze after two weeks of arsenic exposure of 100 μg/L during adulthood [66]. More detail on therapeutic interventions after arsenic exposure will be discussed in later sections of this review. Overall, work with animal models has demonstrated that arsenic induces deficits in multiple learning paradigms, particularly those relying on proper hippocampal function. Yet, identifying the hippocampus as a sensitive area for arsenic’s effects does not necessarily identify a molecular target. Alterations in multiple signaling pathways are localized to the hippocampal formation, but it should be noted that mossy fiber terminals in the hippocampus contain substantial amounts of zinc. Thus, the sensitivity of the hippocampus may be due to the effect of arsenic on zinc either via displacement or substitution. To date, no studies investigating this mechanism have been published.

Glutamatergic Signaling

Arsenic impacts the synaptic activity of neurons localized to the hippocampus. Slices obtained from young and adult rats exposed to 100 μM arsenite in vitro had reduced amplitudes of excitatory post synaptic potentials (EPSPs) in the Schaffer collateral/CA1 synapses. Exposure inhibited long-term potentiation (LTP), a form of synaptic plasticity, in hippocampal slices from adult but not young rats; however, this effect was reversible after 20 minutes of washout. Arsenic exposure did not impair paired-pulse facilitation, indicative of presynaptic activity, suggesting that acutely applied arsenic does not affect presynaptic neurotransmitter release [70]. However, components of NMDA receptors, specifically NR2A, were reduced after three months of arsenic exposure (2.72, 13.6, 68 mg/L arsenic) in mice. Additionally, these mice exhibited morphological changes in hippocampal neurons—reduced size with a condensed nucleus and cytoplasm—along with capillary edema and irregular vascular endothelial cell morphology [71]. Similar morphological changes in hippocampal neurons were observed after a 3-month exposure of 8.2 mg/kg/day arsenic; both the striatum and hippocampus contained abnormally myelinated nerve fibers, while the hippocampus contained reduced mossy fiber terminals [68]. Brief, two week exposure to 100 μM arsenic also altered expression levels of mRNA for synapse related genes, including increased Grin1, Syn2, and Stx6 expression, similar to results from our studies [63, 72].

In addition to altered synaptic activity and synapse-related gene expression, arsenic has been shown to impart alterations in central pathways involved in mediating learning and memory in the hippocampus. Using a three-month exposure model (from weaning until four months), arsenic-exposed animals had decreased NR2A expression, PSD-95, and p-CAMKIIα in the hippocampus with concurrent increased SynGAP expression, a known negative regulator of the Ras-MAPK pathway [73]. Reduced p-ERK1/2 in the hippocampus was also observed in the arsenic-exposed animals. These findings corroborate our own work demonstrating reduced ERK2 in the hippocampus after perinatal exposure to arsenic [74]. Thus, the Ras-MAPK/ERK pathway appears to be sensitive to arsenic damage; interestingly, zinc has been shown to alter this pathway as well [75]. It is possible that arsenic is acting in a similar fashion. Overall, altered Ras-MAPK/ERK signaling, LTP, and synaptic regulation in the hippocampus could underlie behavioral deficits suggesting arsenic-induced alterations in long-term episodic memory, associative learning, spatial learning, and working memory.

Glucocorticoid Signaling

In addition to altered hippocampal-dependent behaviors, depressive-like symptoms have been observed in arsenic-exposed mice. We have demonstrated increased immobility in the forced swim task and increased latency for escape in the learned helplessness task, along with increased plasma corticosterone levels [74]. Corticosterone (CORT), the rodent equivalent of cortisol, is a stress hormone that plays a role in mediating the effects of the hypothalamus-pituitary-adrenal (HPA) axis in response to “stressful” events ranging from fear to learning. In humans, significant alterations in the HPA axis have been connected to depressive-like symptoms, and patients with depression typically report stress as a major factor in the onset of their depression. Thus, decreased behavioral ability and increased depressive-symptoms in arsenic-exposed animals correlate with the epidemiological data on reduced cognition in humans; as such, arsenic may be mediating not only cognitive impairments but also mood disorders in humans via the glucocorticoid signaling pathway.

CORT signaling is mediated through the corticosterone receptors, specifically the mineralocorticoid (MR) and glucocorticoid (GR) receptors. When activated, MR and GR translocate to the nucleus to allow for binding to response elements (MRE or GRE) on genes for transcriptional activation or repression. CORT signaling, via its receptors in the hippocampus, is responsible for imparting an inhibitory tone for the HPA axis. Our work has demonstrated nuclear levels of GR are much lower in adult mice perinatally exposed to arsenic than levels observed in controls in hippocampal tissue [67]. Additionally, we have shown decreased GR binding to and expression of H-Ras and Raf-1, genes involved in modulating the MAPK pathway with GRE binding sites [76]. In vitro studies have demonstrated that various levels of arsenic impact GR-mediated transcription in a bidirectional manner: high arsenic levels (1-3 μM) induce an inhibitory effect, while low levels (0.05–1 μM) seem to produce a stimulatory effect [77]. Arsenic’s impact on GR is predicated on the DNA binding domain (DBD) within the GR. Other steroid receptors, including the MR and the progesterone receptor respond to arsenic in a similar biphasic manner as the GR [78]. Interestingly, arsenic’s effects on transcriptional regulation of the estrogen receptor seem to be only inhibitory [79]. A recent study predicted that the GR pathway was a common mediator of metal-induced birth defects: indeed, arsenic-induced deficits, specifically neurodevelopmental toxicity, were prevented by inhibition of GR signaling in a chick embryo model [80]. Oscillatory signaling of the HPA axis, in addition to proper GR localization for MAPK activation, is paramount for proper learning and memory. This signaling may be impaired in arsenic-exposed animals: while they have elevated circulating CORT, their ability to initiate a proper HPA response is blunted after a stressor [81•]. Thus, the susceptibility of the GR to arsenic may play an important role in hippocampal-related deficits, including reduced learning and increased depressive-like symptoms (observed in rodent models) and may underlie mood and cognitive deficits seen in human studies as well.

Cholinergic Signaling

Motor learning, cholinergic signaling, and locomotion are all affected by arsenic exposure in rodent models. Early studies demonstrated impaired motor coordination and delayed spontaneous alteration in rats chronically consuming arsenic (36 mg/L) for four months [82]. However the increased locomotion reported in this study has been challenged by more recent work: while altered locomotion is a common behavior seen in arsenic-exposed mice, whether this behavior is hypo- or hyperlocomotion seems to be dependent on sex and the arsenic exposure paradigm (see Table 3 for studies). Low levels of arsenic exposure seem to induce hyperactivity in male mice, while high levels induce hypoactivity [83, 84]. Conversely, female mice consuming any level of arsenic display hyperlocomotion [83]. Subchronic exposures to arsenic increase locomotion but impair motor coordination in both sexes [85], but reports on in utero exposure are conflicting, with some suggesting impaired neural reflexes and others reporting no changes in locomotor behavior [86, 87]. A similar dose relationship between locomotion and arsenic level occurs in the zebrafish model, where moderate arsenic levels reduced locomotion (line crossing) and high levels increased the distance travelled [88]. Details on these studies, including dose, timing of exposure, and age of behavioral assessment are provided in Table 3. While parsing out verifiable locomotor actions from anxiety is difficult and likely to impact these studies, we can ascertain that high concentrations of arsenic induce hypolocomotion, moderate levels of arsenic induce hyperlocomotion, and low concentrations may induce no change in locomotion.

Altered motor coordination and locomotion could arise from abberant cholinergic functioning. Several reports have noted reduced acetylcholinesterase (AchE) activity and choline acetyltransferase (ChAT) functioning after arsenic exposure. Female rats exposed to 20 mg/kg arsenic for 28 days displayed deficits in the transfer latency of the passive avoidance response and decreased labeling of muscarinic cholinergic receptors in the hippocampus and frontal cortex [89]. These brain regions had reduced AchE activity and ChAT labeling after arsenic exposure as well. Interestingly, treatment with a bioactive component of the spice curcumin during arsenic exposure attenuated these observed effects in female rats [89]. Exposure to less arsenic (5 mg/kg body weight) also inhibited AchE activity in the brain and was associated with poorer performance in operant learning [90]; another study demonstrated that AchE activity decreased with increasing arsenic concentrations in male rats after five days of exposure [91]. Our analyses have shown that mRNA of AchE is increased in the adult dentate gyrus after developmental arsenic expoure to 50 μg/L arsenic, suggesting a compensatory mechanism for altered AchE activity [72]. These studies provide support for arsenic in the etiology of Alzheimer’s disease, as more reports confirm reduced AchE and ChAT along with degeneration of cholinergic neurons in AD pathology [92].

Alzheimer’s Disease

Global cognitive impairments assessed after arsenic exposure have been associated with Alzheimer’s disease (AD) in the human population; for an in-depth assessment of the relationship between arsenic and Alzheimer’s disease, see [93]. For the purposes of this review, we will discuss arsenic exposure in the context of experimental studies. In vitro research using a cholinergic neuronal cell line has demonstrated that sodium arsenite and dimethylarsinic acid (DMA) have different effects on APP protein levels, β-amyloid formation, and altered activity of AchE and ChAT [94]. These findings corroborate our own: we have found altered mRNA expression of genes associated with AD, including Appb1 and ApoE, and Ache in the dentate gyrus of adult male mice after developmental exposure to 50 μg/L arsenic [72].

For hallmark pathologies associated with AD, cell culture studies have demonstrated arsenic exposure increases β-amyloid protein and induces hyper-phosphorylation of tau protein, oxidative stress, inflammation, endothelial cell dysfunction, and angiogenesis [95]. Interestingly, zinc has also been shown to induce tau phosphorylation through an ERK-sensitive mechanism [96]; again, this effect may be due to a cation sensitive system (to zinc or arsenic) involving the Ras-MAPK/ERK pathway. In 2012, Piacentini and colleagues provided further evidence supporting the role of arsenic in the etiology of AD. The authors found a significant correlation between a genetic polymorphism of the protein glutathione S-transferase GSTO1-1 in a population of 120 AD patients compared to 114 healthy controls (OR = 3.70); this transferase has been linked to both Alzheimer’s and Parkinson’s disease and is involved in arsenic metabolism, even in invertebrate systems [97, 98, 99]. While arsenic does not participate directly in REDOX reactions, it can induce oxidative stress via depletion of glutathione and impair REDOX reactions by inhibiting enzymes with sulfhydryl groups [100]; and oxidative damage is strongly associated with AD. In rodent models, arsenic exposure results in vascular endothelial dysfunction, impairment of learning and memory, altered nitrogen levels, and oxidative stress; all of which have been associated with symptoms of dementia [66]. Treatment with a histone deacetylase inhibitor, sodium butyrate, attenuated these cognitive and vascular deficits observed in arsenic-exposed animals [66]. Sodium butyrate has been used in the treatment of depression and improves cognitive skills in the Alzheimer’s mouse model (APP/PS1-21) [101]. Overall, we confidently state that arsenic imparts cognitive deficits associated with AD in rodent studies of exposure; however, very few epidemiological studies have investigated this relationship to date.

Monoaminergic Signaling

Arsenic affects many transporter systems including the monoamines, dopamine (DA), serotonin (5-HT), and norepinephrine (NE). We have demonstrated that very low doses of arsenic (50 μg/L) during development increase 5-HT1A receptors in the dorsal hippocampus in adult offspring [74]. Exposure to moderate levels of arsenic (1, 2, and 4 mg/L) in water for 60 days reduced levels of NE, DA, and 5-HT in both the cerebrum and cerebellum of 7-week old mice in a dose-dependent manner. mRNA levels of monoamine synthetases (including dopamine β-hydroxylase, tyrosine hydroxylase (TH), and tryptophan hydroxylase) were also all reduced after exposure to 4 mg/L arsenic [102]. Evidence from other studies using low to moderate doses of arsenic suggest differential effects on monoaminergic signaling based on sex, as observed in locomotion tasks. Four months of chronic exposure to 0.05, 0.5, 5.0, or 50 mg/L arsenic in drinking water decreased levels of DA in the striatum and hypothalamus in females (who also exhibited increased locomotion) but not in males [83]. TH and thioredoxin (Trx-1 A) levels were reduced in the striatum of males but not females; curiously, the opposite effect was observed in the nucleus accumbens where TH and Trx-1A were reduced in females but not males [83]. Conversely, in a different study on rats ingesting 50 mg/L arsenic in water, DA content in the striatum was increased in males, although no changes in DA, its metabolites, or serotonin were found in the prefrontal cortex or the nucleus accumbens [84]. This group also reported alterations in mRNA of several antioxidant genes including superoxide dismutase (SOD), Trx-1, and NE and DA receptor genes in arsenic-exposed animals dependent on dose and region of interest in the brain (nucleus accumbens, prefrontal cortex, or striatum). Upregulation of antioxidant factors (Trx-1 and SOD) indicate compensatory mechanisms to overcome the oxidative byproduct effects of arsenic toxicity on thiol containing enzymes related to arsenic metabolism [84]. It is difficult to propose a mechanism of action for opposite effects based on sex for different brain regions. However, evidence from these studies, while conflicting, suggest that arsenic may induce a complex dose-response relationship, which may not be linear, on locomotion and the nigrostriatal dopaminergic system as seen in other studies.

High levels of arsenic exposure, which have been reviewed elsewhere, produce more definitive deficits on dopaminergic and serotonergic signaling in the corpus striatum, hippocampus, and frontal cortex [85, 103]. Interestingly, treatment with curcumin in these studies attenuates deficits in monoamines and increases nitric oxide (NO) and TH expression, in both sexes. More details on therapeutic strategies to combat arsenic toxicity will be provided later.

Neurogenesis

Deficits in hippocampal-related behavioral tasks and increased depressive-like symptoms suggest that arsenic exposure induces changes in hippocampal morphology. Recent studies have demonstrated deficits in adult neurogenesis in the dentate gyrus of the hippocampus in both developmental and adult exposures to arsenic. Treatment for four months with 4 μg/L arsenic in drinking water reduced proliferation of neural progenitor cells and the number of mature neurons [104•]. Developmental exposure of 50 μg/L arsenic (in utero and postnatal) altered differentiation but not proliferation of neural progenitor cells in the adult hippocampus at PND63 [72]. In both studies, deficits in adult neurogenesis were ameliorated either after cessation of the use of arsenic in water [104•] or with experience in an enriched environment [72]. In vitro studies using P19 pluripotent cells cultured with varying concentrations of arsenic (7.5-75.0 μg/L) demonstrated that arsenic inhibited the formation of muscle and neuronal cells during P19 cell differentiation in a dose dependent manner. Deficits in neuronal differentiation may have resulted from reduced expression of transcription factors including neurogenin 1, neurogenin 2, and NeuroD as compared to control P19 cultures. Further, Nanog expression increased during cell differentiation, suggesting that arsenic impacts differentiation but not proliferation [105].

Altered hippocampal morphology in CA1, CA3, and the dentate gyrus was also observed during postnatal development after I.P. injection of 1, 1.5, and 2.0 mg/kg arsenic from PND4-11 [106]. Two weeks of 100 μM exposure to arsenic reduced GFAP staining in the hippocampus in another study, indicative of less neural stem cells [63], while exposure to arsenic induced deficits in cell proliferation and increased apoptosis in the brains of zebrafish [107]. These studies suggest many different types of exposures to arsenic, including brief, chronic, adult, or developmental, can impact the morphology of the hippocampus. The effect of arsenic on neurogenesis may be mediated through a signaling mechanism already discussed: altered glucocorticoid and HPA axis function. Neurogenesis is a particularly sensitive process in the brain, and as such, is prone to insults like stress activity. Recent in vitro studies done in human hippocampal progenitor cells have demonstrated biphasic responses of adult neurogenesis to cortisol; of particular interest is that increased cortisol levels inhibit proliferation and differentiation possibly mediated by the GR [108]. However, the effect of the GR on adult neurogenesis is complex, as proposed by work showing antidepressants mediate an increase in adult hippocampal neurogenesis by activating the GR [109] as well. Arsenic has an impact on adult neurogenesis and hippocampal-dependent learning and memory and induces cognitive deficits and depressive-like symptoms; altered HPA axis regulation, and particularly GR signaling in the hippocampus could underlie all of these alterations seen in arsenic-exposed animals.

Summary

Arsenic can alter a multitude of systems in the brain. Of particular interest is HPA axis dysregulation that may underlie several behavioral deficits, particularly related to the hippocampus including alterations in adult neurogensis and Ras-MAPK/ERK signaling. Additionally, arsenic seems to have an impact on cholinergic and monoaminergic signaling, though the mechanisms are not well understood at this point. Rodent studies have provided useful corroboration of the epidemiological evidence suggesting that a number of mechanisms could underlie cognitive deficits and mood disorders observed in human populations. More research focused on the dynamics of epigenetics, particularly on mechanisms of learning and memory and mood, will be important for understanding the impact of arsenic on the brain. While it is unlikely one common unifying mechanism for arsenic’s effects will be identifed, some clues on how naturally present cations, like zinc, interact with the system, may provide insight.

Therapeutics

Some arsenic-induced deficits have been ameliorated with therapeutics. For example, in rodent studies, deficits in adult neurogenesis can be attenuated either by abolishment of exposure to arsenic water [104•], experience in an enriched environment [72], or chronic antidepressant treatment (our unpublished observations). Reduced expression of monoamines after arsenic exposure can be reversed by treatment with curcumin [85] or taurine [102]. Studies described here have demonstrated that use of selenium, zinc, arsenic chelators, and environmental enrichment can attenuate systemic deficits due to arsenic exposure.

The use of selenium as an anti-carcinogen and chemoprotective compound and its interaction with arsenic has been extensively studied in the cancer field. Selenium forms conjugates with arsenic using glutathione for excretion [110]. A study on selenium concentrations in adults and children reported an inverse correlation between blood concentrations of selenium and urinary concentrations of arsenic [111]. In rodent studies, selenium concentrations in the cerebrum and cerebellum are reduced after exposure to 1-4 mg/L arsenic [112]. Treatment with selenium (Se) can attenuate some arsenic-induced deficits such as the inhibition of AchE in arsenic-exposed fish (Channa punctatu), particularly if Se treatment precedes arsenic exposure [113]. Another naturally occurring metal, zinc, is an important component of several enzymes involved in development and CNS function. Concurrent exposure to 40 mg/kg arsenic and 4 % w/v zinc in drinking water during pregnancy induced no teratological deficits or arsenic toxicity in male offspring, as seen in arsenic-only exposure. No changes were observed in sensory reflexes, glutathione, or motor behavior, suggesting that zinc treatment attenuated arsenic-induced deficts in mice [114]. Zinc has also been shown to be protective against arsenic-induced apoptosis in neurons in vitro [115]. The mechanism by which zinc prevents arsenic-induced toxicity has not been eluciated, but we hypothesize that the Ras-MAPK/ERK pathway is involved.

In India, where efforts for intervention of arsenic-induced toxicity are at the forefront of research, the use of chelators has been suggested for attenuating the effects of chronic arsenic exposure, including thiol chelators that form insoluble complexes with arsenic [116]. One such chelator is monoisoamyl meso-2-3-dimercaptosuccinic acid (MiADMSA), a lipophilic analog of DMSA and a strong thiol chelator. Five days of MiADMSA was provided for treatment of male rats after 10 weeks of exposure to 2 mg/kg arsenic. Compared to control animals, arsenic-exposed rats displayed decreased locomotor activity, fore and hind limb strength, reduced exploration, and impaired learning in the morris water maze. Additionally, reduced levels of malondialdehyde and oxidative stress markers including superoxide dismutase, glutathione peroxidase, glutathione reductase, and glutathione transferase were measured in the cerebellum, hippocampus, and most notably, the frontal cortex. Treatment with MiADMSA attenuated all of these effects but failed to restore performance back to control levels [117].

Other notable interventions include high protein diet, antidepressants, curcumin, and exposure to enriched envrionments. Casein and pea protein, both of which have antioxidant proteins, protected against the effects of arsenic on reproductive measures in female rats [118], while curcumin in the diet attenuated the effects of arsenic on malonaldehyde, glutathione, and superoxide dismutase in several key brain regions, including decreased TH expression in the striatum [85]. Our own studies of treatment with fluoxetine (Prozac) or exposure to an enriched environment after developmental arsenic exposure suggests that the insults arsenic imparts can be ameliorated [72]. Research on therapeutic approaches will become more pronounced as the number of people exposed to arsenic increases. However, efforts to implement safe water programs have been successful in reducing arsenic exposure in some parts of the world [119]. Arsenic remediation endeavors remain the most effective method for reducing exposure to this insidious toxic metalloid.

Conclusion

The most recent report provided by the Agency for Toxic Substances and Disease Registry (ATSDR) has suggested that toxic exposures to arsenic may result in memory loss and emotional instability in humans. Epidemiological studies from the past decade have provided a wealth of information supporting a strong correlation between arsenic exposure and neurological and cognitive dysfunction in children and adults. These deficits seem to be dependent on concentration, timing, and duration of exposure, with cumulative arsenic inducing more severe insults. Developmental exposure to arsenic may impart damage on critical processes involved in programming in the brain. Research in rodent models has provided sufficient evidence to suggest that arsenic toxicity affects multiple systems and specific pathways involved in several aspects of learning, memory, movement, decision making, and mood. The next phases of research will delve deeper into mechanisms of action including epigenetics and specifically focus on therapeutics for the treatment of arsenic toxicity on the brain. More information on health and exposure during the intrauterine period could be helpful in ascertaining the true impact of arsenic exposure on the central nervous system. Additionally, more epidemiological studies, particularly in the United States, would be useful in determining if the current standard (10 μg/L) will be sufficient enough to block arsenic-induced neurotoxicity, and if not, what can be done, either legislatively or pharmaceutically to alleviate arsenic-mediated cognitive deficits.

Notes

Acknowledgments

The authors would like to thank Dr. Andrew Roland and Ms. Samantha Goggin for critical reading of the manuscript. This work was supported by grants from the National Institutes of Health (NIH) grants MH101984 (CRT) and RO1ES019583 (AMA).

Christina R. Tyler has received grant support from National Institutes of Health: NIMH.

Andrea M. Allan has received grant and travel support from PHS-NIH-NIEHS. She has received NAL study section travel costs covered by PHS.

Compliance with Ethics Guidelines

Conflict of Interest

The authors declare no conflict of interest

Christina R. Tyler is a graduate student in the Neurosciences Department employed by the University of New Mexico.

Dr. Andrea M. Allan is a tenured Professor at the University of New Mexico in the Neurosciences Department. She has received fees for participation in PHS1053 CSR study section grant review, as well as a Texas Tech speaking fee.

Human and Animal Rights and Informed Consent

This article does contain published studies with animal subjects performed by the authors.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Hughes MF et al. Arsenic exposure and toxicology: a historical perspective. Toxicol Sci. 2011;123(2):305–32.PubMedCentralPubMedGoogle Scholar
  2. 2.
    Naujokas MF et al. The broad scope of health effects from chronic arsenic exposure: update on a worldwide public health problem. Environ Health Perspect. 2013;121(3):295–302.PubMedCentralPubMedGoogle Scholar
  3. 3.
    Wilson D, Hooper C, Shi X. Arsenic and lead in juice: apple, citrus, and apple-base. J Environ Health. 2012;75(5):14–20. quiz 44.PubMedGoogle Scholar
  4. 4.
    Gosse JA et al. Monomethylated trivalent arsenic species disrupt steroid receptor interactions with their DNA response elements at non-cytotoxic cellular concentrations. J Appl Toxicol. 2013. doi: 10.1002/jat.2898.PubMedGoogle Scholar
  5. 5.
    Kligerman AD et al. Methylated trivalent arsenicals as candidate ultimate genotoxic forms of arsenic: induction of chromosomal mutations but not gene mutations. Environ Mol Mutagen. 2003;42(3):192–205.PubMedGoogle Scholar
  6. 6.
    Watanabe T, Hirano S. Metabolism of arsenic and its toxicological relevance. Arch Toxicol. 2013;87(6):969–79.PubMedGoogle Scholar
  7. 7.
    Kruger K et al. Effects of monomethylarsonic and monomethylarsonous acid on evoked synaptic potentials in hippocampal slices of adult and young rats. Toxicol Appl Pharmacol. 2009;236(1):115–23.PubMedGoogle Scholar
  8. 8.
    Ventura-Lima J, Bogo MR, Monserrat JM. Arsenic toxicity in mammals and aquatic animals: a comparative biochemical approach. Ecotoxicol Environ Saf. 2011;74(3):211–8.PubMedGoogle Scholar
  9. 9.
    Sanchez-Pena LC et al. Arsenic species, AS3MT amount, and AS3MT gene expression in different brain regions of mouse exposed to arsenite. Environ Res. 2010;110(5):428–34.PubMedGoogle Scholar
  10. 10.
    Vahter M. Effects of arsenic on maternal and fetal health. Annu Rev Nutr. 2009;29:381–99.PubMedGoogle Scholar
  11. 11.
    He W et al. Arsenic exposure in pregnant mice disrupts placental vasculogenesis and causes spontaneous abortion. Toxicol Sci. 2007;99(1):244–53.PubMedGoogle Scholar
  12. 12.
    Ahmed S et al. Arsenic-associated oxidative stress, inflammation, and immune disruption in human placenta and cord blood. Environ Health Perspect. 2011;119(2):258–64.PubMedCentralPubMedGoogle Scholar
  13. 13.••
    Rodriguez-Barranco M et al. Association of arsenic, cadmium and manganese exposure with neurodevelopment and behavioural disorders in children: a systematic review and meta-analysis. Sci Total Environ. 2013;454-455:562–77. Comprehensive meta-analysis of research focusing on the impact of arsenic exposure on intellegence (IQ) in children.PubMedGoogle Scholar
  14. 14.
    Rosado JL et al. Arsenic exposure and cognitive performance in Mexican schoolchildren. Environ Health Perspect. 2007;115(9):1371–5.PubMedCentralPubMedGoogle Scholar
  15. 15.
    Roy A et al. Association between arsenic exposure and behavior among first-graders from Torreon, Mexico. Environ Res. 2011;111(5):670–6.PubMedGoogle Scholar
  16. 16.
    von Ehrenstein OS et al. Children's intellectual function in relation to arsenic exposure. Epidemiology. 2007;18(1):44–51.Google Scholar
  17. 17.
    Wasserman GA et al. Water arsenic exposure and children's intellectual function in Araihazar, Bangladesh. Environ Health Perspect. 2004;112(13):1329–33.PubMedCentralPubMedGoogle Scholar
  18. 18.
    Wang SX et al. Arsenic and fluoride exposure in drinking water: children's IQ and growth in Shanyin county, Shanxi province, China. Environ Health Perspect. 2007;115(4):643–7.PubMedCentralPubMedGoogle Scholar
  19. 19.
    Llop S et al. Gender differences in the neurotoxicity of metals in children. Toxicology. 2013;311(1–2):3–12.PubMedGoogle Scholar
  20. 20.
    Gardner RM et al. Environmental exposure to metals and children's growth to age 5 years: a prospective cohort study. Am J Epidemiol. 2013;177(12):1356–67.PubMedCentralPubMedGoogle Scholar
  21. 21.
    Kang J et al. Effects of arsenic in drinking water on children's intelligence. Wei Sheng Yan Jiu. 2007;36(3):347–9.PubMedGoogle Scholar
  22. 22.
    Wasserman GA et al. Developmental impacts of heavy metals and undernutrition. Basic Clin Pharmacol Toxicol. 2008;102(2):212–7.PubMedGoogle Scholar
  23. 23.
    Parajuli RP et al. Association of cord blood levels of lead, arsenic, and zinc with neurodevelopmental indicators in newborns: a birth cohort study in Chitwan Valley, Nepal. Environ Res. 2013;121:45–51.PubMedGoogle Scholar
  24. 24.
    Hamadani JD et al. Pre- and postnatal arsenic exposure and child development at 18 months of age: a cohort study in rural Bangladesh. Int J Epidemiol. 2010;39(5):1206–16.PubMedGoogle Scholar
  25. 25.
    Tofail F et al. Effect of arsenic exposure during pregnancy on infant development at 7 months in rural Matlab, Bangladesh. Environ Health Perspect. 2009;117(2):288–93.PubMedCentralPubMedGoogle Scholar
  26. 26.•
    Hamadani JD et al. Critical windows of exposure for arsenic-associated impairment of cognitive function in pre-school girls and boys: a population-based cohort study. Int J Epidemiol. 2011;40(6):1593–604. In-depth study focusing on maternal and early childhood exposure to arsenic; demonstrates differential effect of arsenic on sex and cognition.PubMedGoogle Scholar
  27. 27.
    Tsai SY et al. The effects of chronic arsenic exposure from drinking water on the neurobehavioral development in adolescence. Neurotoxicology. 2003;24(4–5):747–53.PubMedGoogle Scholar
  28. 28.
    Wright RO et al. Neuropsychological correlates of hair arsenic, manganese, and cadmium levels in school-age children residing near a hazardous waste site. Neurotoxicology. 2006;27(2):210–6.PubMedGoogle Scholar
  29. 29.
    Harkins DK, Susten AS. Hair analysis: exploring the state of the science. Environ Health Perspect. 2003;111(4):576–8.PubMedCentralPubMedGoogle Scholar
  30. 30.
    Wasserman GA et al. Water arsenic exposure and intellectual function in 6-year-old children in Araihazar, Bangladesh. Environ Health Perspect. 2007;115(2):285–9.PubMedCentralPubMedGoogle Scholar
  31. 31.
    Rai A et al. Characterization of developmental neurotoxicity of As, Cd, and Pb mixture: synergistic action of metal mixture in glial and neuronal functions. Toxicol Sci. 2010;118(2):586–601.PubMedGoogle Scholar
  32. 32.
    Aelion CM et al. Metal concentrations in rural topsoil in South Carolina: potential for human health impact. Sci Total Environ. 2008;402(2–3):149–56.PubMedCentralPubMedGoogle Scholar
  33. 33.
    McDermott S et al. Probability of intellectual disability is associated with soil concentrations of arsenic and lead. Chemosphere. 2011;84(1):31–8.PubMedCentralPubMedGoogle Scholar
  34. 34.
    Wasserman GA et al. Arsenic and manganese exposure and children's intellectual function. Neurotoxicology. 2011;32(4):450–7.PubMedGoogle Scholar
  35. 35.
    Drews-Botsch C et al. Socioeconomic differences and the impact of being small for gestational age on neurodevelopment among preschool-aged children. Rev Environ Health. 2011;26(3):221–9.PubMedGoogle Scholar
  36. 36.
    Dong J, Su SY. The association between arsenic and children's intelligence: a meta-analysis. Biol Trace Elem Res. 2009;129(1–3):88–93.PubMedGoogle Scholar
  37. 37.
    Rocha-Amador D et al. Decreased intelligence in children and exposure to fluoride and arsenic in drinking water. Cad Saude Publica. 2007;23 Suppl 4:S579–87.PubMedGoogle Scholar
  38. 38.
    Beard J. Iron deficiency alters brain development and functioning. J Nutr. 2003;133(5 Suppl 1):1468S–72.PubMedGoogle Scholar
  39. 39.
    Heck JE et al. Arsenic exposure and anemia in Bangladesh: a population-based study. J Occup Environ Med. 2008;50(1):80–7.PubMedGoogle Scholar
  40. 40.
    Dominguez-Salas P et al. DNA methylation potential: dietary intake and blood concentrations of one-carbon metabolites and cofactors in rural African women. Am J Clin Nutr. 2013;97(6):1217–27.PubMedCentralPubMedGoogle Scholar
  41. 41.
    Heck JE et al. Dietary intake of methionine, cysteine, and protein and urinary arsenic excretion in Bangladesh. Environ Health Perspect. 2009;117(1):99–104.PubMedCentralPubMedGoogle Scholar
  42. 42.
    Calderon J et al. Exposure to arsenic and lead and neuropsychological development in Mexican children. Environ Res. 2001;85(2):69–76.PubMedGoogle Scholar
  43. 43.••
    O'Bryant SE et al. Long-term low-level arsenic exposure is associated with poorer neuropsychological functioning: a Project FRONTIER study. Int J Environ Res Public Health. 2011;8(3):861–74. Important study demonstrating the inverse relationship between cumulative arsenic exposure and adult cognition; however, arsenic assessments were conducted using GIS software instead of direct analysis.PubMedCentralPubMedGoogle Scholar
  44. 44.•
    Gong G et al. Low-level groundwater arsenic exposure impacts cognition: a project FRONTIER study. J Environ Health. 2011;74(2):16–22. Interesting study from the the United States demonstating the association between very low arsenic exposure (10 ppb on par with EPA standards) and impaired cognitive function in adults.PubMedGoogle Scholar
  45. 45.
    Rosselli M et al. The relation of education and gender on the attention items of the Mini-Mental State Examination in Spanish speaking Hispanic elders. Arch Clin Neuropsychol. 2006;21(7):677–86.PubMedCentralPubMedGoogle Scholar
  46. 46.
    Franco-Marina F et al. The Mini-mental State Examination revisited: ceiling and floor effects after score adjustment for educational level in an aging Mexican population. Int Psychogeriatr. 2010;22(1):72–81.PubMedGoogle Scholar
  47. 47.
    Syed EH et al. Quality of life and mental health status of arsenic-affected patients in a Bangladeshi population. J Health Popul Nutr. 2012;30(3):262–9.PubMedCentralPubMedGoogle Scholar
  48. 48.
    Garelick H et al. Arsenic pollution sources. Rev Environ Contam Toxicol. 2008;197:17–60.PubMedGoogle Scholar
  49. 49.
    Guo JX et al. Chronic arsenic poisoning in drinking water in Inner Mongolia and its associated health effects. J Environ Sci Health A Tox Hazard Subst Environ Eng. 2007;42(12):1853–8.PubMedGoogle Scholar
  50. 50.
    Dang WM et al. Investigation on mental health of residents living in a mineral area in Hubei province. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2008;26(8):457–60.PubMedGoogle Scholar
  51. 51.
    Fujino Y et al. Mental health burden amongst inhabitants of an arsenic-affected area in Inner Mongolia, China. Soc Sci Med. 2004;59(9):1969–73.PubMedGoogle Scholar
  52. 52.
    Sen D, Sarathi Biswas P. Arsenicosis: is it a protective or predisposing factor for mental illness? Iran J Psychiatry. 2012;7(4):180–3.PubMedCentralPubMedGoogle Scholar
  53. 53.
    Zierold KM, Knobeloch L, Anderson H. Prevalence of chronic diseases in adults exposed to arsenic-contaminated drinking water. Am J Public Health. 2004;94(11):1936–7.PubMedCentralPubMedGoogle Scholar
  54. 54.•
    Martinez L et al. Impact of early developmental arsenic exposure on promotor CpG-island methylation of genes involved in neuronal plasticity. Neurochem Int. 2011;58(5):574–81. First study to demonstrate the impact of arsenic on DNA methylation in genes associated with neuronal plasticity.PubMedGoogle Scholar
  55. 55.
    Reichard JF, Schnekenburger M, Puga A. Long term low-dose arsenic exposure induces loss of DNA methylation. Biochem Biophys Res Commun. 2007;352(1):188–92.PubMedCentralPubMedGoogle Scholar
  56. 56.
    Bailey KA et al. Arsenic and the epigenome: interindividual differences in arsenic metabolism related to distinct patterns of DNA methylation. J Biochem Mol Toxicol. 2013;27(2):106–15.PubMedCentralPubMedGoogle Scholar
  57. 57.
    Kile ML et al. Prenatal arsenic exposure and DNA methylation in maternal and umbilical cord blood leukocytes. Environ Health Perspect. 2012;120(7):1061–6.PubMedCentralPubMedGoogle Scholar
  58. 58.
    Koestler DC et al. Differential DNA methylation in umbilical cord blood of infants exposed to low levels of arsenic in utero. Environ Health Perspect. 2013;121(8):971–7.PubMedCentralPubMedGoogle Scholar
  59. 59.
    Reichard JF, Puga A. Effects of arsenic exposure on DNA methylation and epigenetic gene regulation. Epigenomics. 2010;2(1):87–104.PubMedCentralPubMedGoogle Scholar
  60. 60.
    Chervona Y et al. Associations between arsenic exposure and global posttranslational histone modifications among adults in Bangladesh. Cancer Epidemiol Biomarkers Prev. 2012;21(12):2252–60.PubMedCentralPubMedGoogle Scholar
  61. 61.
    Zhou X et al. Effects of nickel, chromate, and arsenite on histone 3 lysine methylation. Toxicol Appl Pharmacol. 2009;236(1):78–84.PubMedCentralPubMedGoogle Scholar
  62. 62.
    Zhou X et al. Arsenite alters global histone H3 methylation. Carcinogenesis. 2008;29(9):1831–6.PubMedCentralPubMedGoogle Scholar
  63. 63.
    Cronican AA et al. Genome-wide alteration of histone H3K9 acetylation pattern in mouse offspring prenatally exposed to arsenic. PLoS One. 2013;8(2):e53478.PubMedCentralPubMedGoogle Scholar
  64. 64.
    Zarazua S et al. Decreased arginine methylation and myelin alterations in arsenic exposed rats. Neurotoxicology. 2010;31(1):94–100.PubMedGoogle Scholar
  65. 65.
    Zhou X et al. Arsenite interacts selectively with zinc finger proteins containing C3H1 or C4 motifs. J Biol Chem. 2011;286(26):22855–63.PubMedCentralPubMedGoogle Scholar
  66. 66.
    Sharma B, Sharma PM. Arsenic toxicity induced endothelial dysfunction and dementia: pharmacological interdiction by histone deacetylase and inducible nitric oxide synthase inhibitors. Toxicol Appl Pharmacol. 2013;273(1):180–8.PubMedGoogle Scholar
  67. 67.
    Martinez-Finley EJ, Ali AM, Allan AM. Learning deficits in C57BL/6 J mice following perinatal arsenic exposure: consequence of lower corticosterone receptor levels? Pharmacol Biochem Behav. 2009;94(2):271–7.PubMedCentralPubMedGoogle Scholar
  68. 68.
    Jing J et al. Changes in the synaptic structure of hippocampal neurons and impairment of spatial memory in a rat model caused by chronic arsenite exposure. Neurotoxicology. 2012;33(5):1230–8.PubMedGoogle Scholar
  69. 69.
    de Castro MR et al. Behavioral and neurotoxic effects of arsenic exposure in zebrafish (Danio rerio, Teleostei: Cyprinidae). Comp Biochem Physiol C Toxicol Pharmacol. 2009;150(3):337–42.PubMedGoogle Scholar
  70. 70.
    Kruger K et al. Effects of arsenite on long-term potentiation in hippocampal slices from young and adult rats. Toxicol Lett. 2006;165(2):167–73.PubMedGoogle Scholar
  71. 71.
    Luo JH et al. Effects of arsenic exposure from drinking water on spatial memory, ultra-structures and NMDAR gene expression of hippocampus in rats. Toxicol Lett. 2009;184(2):121–5.PubMedGoogle Scholar
  72. 72.
    Tyler CR, Allan AM. Adult hippocampal neurogenesis and mRNA expression are altered by perinatal arsenic exposure in mice and restored by brief exposure to enrichment. PLoS One. 2013;8(9):e73720.PubMedCentralPubMedGoogle Scholar
  73. 73.
    Luo JH et al. Arsenite exposure altered the expression of NMDA receptor and postsynaptic signaling proteins in rat hippocampus. Toxicol Lett. 2012;211(1):39–44.PubMedGoogle Scholar
  74. 74.
    Martinez EJ et al. Moderate perinatal arsenic exposure alters neuroendocrine markers associated with depression and increases depressive-like behaviors in adult mouse offspring. Neurotoxicology. 2008;29(4):647–55.PubMedCentralPubMedGoogle Scholar
  75. 75.
    Klein C et al. Zinc induces ERK-dependent cell death through a specific Ras isoform. Apoptosis. 2006;11(11):1933–44.PubMedGoogle Scholar
  76. 76.
    Martinez-Finley EJ et al. Reduced expression of MAPK/ERK genes in perinatal arsenic-exposed offspring induced by glucocorticoid receptor deficits. Neurotoxicol Teratol. 2011;33(5):530–7.PubMedCentralPubMedGoogle Scholar
  77. 77.
    Bodwell JE, Kingsley LA, Hamilton JW. Arsenic at very low concentrations alters glucocorticoid receptor (GR)-mediated gene activation but not GR-mediated gene repression: complex dose-response effects are closely correlated with levels of activated GR and require a functional GR DNA binding domain. Chem Res Toxicol. 2004;17(8):1064–76.PubMedGoogle Scholar
  78. 78.
    Bodwell JE et al. Arsenic disruption of steroid receptor gene activation: complex dose-response effects are shared by several steroid receptors. Chem Res Toxicol. 2006;19(12):1619–29.PubMedCentralPubMedGoogle Scholar
  79. 79.
    Davey JC et al. Arsenic as an endocrine disruptor: effects of arsenic on estrogen receptor-mediated gene expression in vivo and in cell culture. Toxicol Sci. 2007;98(1):75–86.PubMedGoogle Scholar
  80. 80.
    Ahir BK et al. Systems biology and birth defects prevention: blockade of the glucocorticoid receptor prevents arsenic-induced birth defects. Environ Health Perspect. 2013;121(3):332–8.PubMedCentralPubMedGoogle Scholar
  81. 81.•
    Goggin SL, Labrecque MT, Allan AM. Perinatal exposure to 50 ppb sodium arsenate induces hypothalamic-pituitary-adrenal axis dysregulation in male C57BL/6 mice. Neurotoxicology. 2012;33(5):1338–45. Comprehensive study assessing the impact of developmental exposure to arsenic on the GR and HPA in adult mice.PubMedCentralPubMedGoogle Scholar
  82. 82.
    Rodriguez VM et al. Effects of sodium arsenite exposure on development and behavior in the rat. Neurotoxicol Teratol. 2002;24(6):743–50.PubMedGoogle Scholar
  83. 83.
    Bardullas U et al. Chronic low-level arsenic exposure causes gender-specific alterations in locomotor activity, dopaminergic systems, and thioredoxin expression in mice. Toxicol Appl Pharmacol. 2009;239(2):169–77.PubMedGoogle Scholar
  84. 84.
    Rodriguez VM et al. Chronic exposure to low levels of inorganic arsenic causes alterations in locomotor activity and in the expression of dopaminergic and antioxidant systems in the albino rat. Neurotoxicol Teratol. 2010;32(6):640–7.PubMedGoogle Scholar
  85. 85.
    Yadav RS et al. Attenuation of arsenic neurotoxicity by curcumin in rats. Toxicol Appl Pharmacol. 2009;240(3):367–76.PubMedGoogle Scholar
  86. 86.
    Luo J et al. Maternal and early life arsenite exposure impairs neurodevelopment and increases the expression of PSA-NCAM in hippocampus of rat offspring. Toxicology. 2013;311(3):99–106.PubMedGoogle Scholar
  87. 87.
    Gandhi DN, Panchal GM, Patel KG. Developmental and neurobehavioural toxicity study of arsenic on rats following gestational exposure. Indian J Exp Biol. 2012;50(2):147–55.PubMedGoogle Scholar
  88. 88.
    Baldissarelli LA et al. Arsenic alters behavioral parameters and brain ectonucleotidases activities in zebrafish (Danio rerio). Comp Biochem Physiol C Toxicol Pharmacol. 2012;155(4):566–72.PubMedGoogle Scholar
  89. 89.
    Yadav RS et al. Neuroprotective efficacy of curcumin in arsenic induced cholinergic dysfunctions in rats. Neurotoxicology. 2011;32(6):760–8.PubMedGoogle Scholar
  90. 90.
    Nagaraja TN, Desiraju T. Effects on operant learning and brain acetylcholine esterase activity in rats following chronic inorganic arsenic intake. Hum Exp Toxicol. 1994;13(5):353–6.PubMedGoogle Scholar
  91. 91.
    Patlolla AK, Tchounwou PB. Serum acetyl cholinesterase as a biomarker of arsenic induced neurotoxicity in sprague-dawley rats. Int J Environ Res Public Health. 2005;2(1):80–3.PubMedCentralPubMedGoogle Scholar
  92. 92.
    Mufson EJ et al. Cholinergic system during the progression of Alzheimer's disease: therapeutic implications. Expert Rev Neurother. 2008;8(11):1703–18.PubMedCentralPubMedGoogle Scholar
  93. 93.
    Gong G, O'Bryant SE. The arsenic exposure hypothesis for Alzheimer disease. Alzheimer Dis Assoc Disord. 2010. doi: 10.1097/WAD.0b013e3181d71bc7.PubMedGoogle Scholar
  94. 94.
    Zarazua S et al. Arsenic affects expression and processing of amyloid precursor protein (APP) in primary neuronal cells overexpressing the Swedish mutation of human APP. Int J Dev Neurosci. 2011;29(4):389–96.PubMedGoogle Scholar
  95. 95.
    Giasson BI et al. The environmental toxin arsenite induces tau hyperphosphorylation. Biochemistry. 2002;41(51):15376–87.PubMedGoogle Scholar
  96. 96.
    Kim I et al. Zinc stimulates tau S214 phosphorylation by the activation of Raf/mitogen-activated protein kinase-kinase/extracellular signal-regulated kinase pathway. Neuroreport. 2011;22(16):839–44.PubMedGoogle Scholar
  97. 97.
    Piacentini S et al. GSTO1*E155del polymorphism associated with increased risk for late-onset Alzheimer's disease: association hypothesis for an uncommon genetic variant. Neurosci Lett. 2012;506(2):203–7.PubMedGoogle Scholar
  98. 98.
    Whitbread AK et al. Characterization of the omega class of glutathione transferases. Methods Enzymol. 2005;401:78–99.PubMedGoogle Scholar
  99. 99.
    Ortiz JG et al. Investigating arsenic susceptibility from a genetic perspective in Drosophila reveals a key role for glutathione synthetase. Toxicol Sci. 2009;107(2):416–26.PubMedGoogle Scholar
  100. 100.
    Jomova K, Valko M. Advances in metal-induced oxidative stress and human disease. Toxicology. 2011;283(2–3):65–87.PubMedGoogle Scholar
  101. 101.
    Govindarajan N et al. Sodium butyrate improves memory function in an Alzheimer's disease mouse model when administered at an advanced stage of disease progression. J Alzheimers Dis. 2011;26(1):187–97.PubMedGoogle Scholar
  102. 102.
    Liu X, Piao F, Li Y. Protective effect of taurine on the decreased biogenic amine neurotransmitter levels in the brain of mice exposed to arsenic. Adv Exp Med Biol. 2013;776:277–87.PubMedGoogle Scholar
  103. 103.
    Yadav RS et al. Neuroprotective effect of curcumin in arsenic-induced neurotoxicity in rats. Neurotoxicology. 2010;31(5):533–9.PubMedGoogle Scholar
  104. 104.•
    Liu S et al. Arsenic-induced inhibition of hippocampal neurogenesis and its reversibility. Neurotoxicology. 2012;33(5):1033–9. First study to demonstrate that adult expsoure to arsenic impairs neurogenesis and that removal of arsenic from drinking water reverses the deficit.PubMedGoogle Scholar
  105. 105.
    Hong GM, Bain LJ. Arsenic exposure inhibits myogenesis and neurogenesis in P19 stem cells through repression of the beta-catenin signaling pathway. Toxicol Sci. 2012;129(1):146–56.PubMedCentralPubMedGoogle Scholar
  106. 106.
    Kaler S et al. Preliminary morphological and immunohistochemical changes in rat hippocampus following postnatal exposure to sodium arsenite. Toxicol Int. 2013;20(2):160–9.PubMedCentralPubMedGoogle Scholar
  107. 107.
    Li D et al. Developmental mechanisms of arsenite toxicity in zebrafish (Danio rerio) embryos. Aquat Toxicol. 2009;91(3):229–37.PubMedGoogle Scholar
  108. 108.
    Anacker C et al. Glucocorticoid-related molecular signaling pathways regulating hippocampal neurogenesis. Neuropsychopharmacology. 2013;38(5):872–83.PubMedCentralPubMedGoogle Scholar
  109. 109.
    Anacker C et al. Antidepressants increase human hippocampal neurogenesis by activating the glucocorticoid receptor. Mol Psychiatry. 2011;16(7):738–50.PubMedCentralPubMedGoogle Scholar
  110. 110.
    Zeng H, Uthus EO, Combs Jr GF. Mechanistic aspects of the interaction between selenium and arsenic. J Inorg Biochem. 2005;99(6):1269–74.PubMedGoogle Scholar
  111. 111.
    George CM et al. A cross-sectional study of the impact of blood selenium on blood and urinary arsenic concentrations in Bangladesh. Environ Health. 2013;12:52.PubMedCentralPubMedGoogle Scholar
  112. 112.
    Wang X et al. Effect of subchronic exposure to arsenic on levels of essential trace elements in mice brain and its gender difference. Biometals. 2013;26(1):123–31.PubMedGoogle Scholar
  113. 113.
    Roy S, Chattoraj A, Bhattacharya S. Arsenic-induced changes in optic tectal histoarchitecture and acetylcholinesterase-acetylcholine profile in Channa punctatus: amelioration by selenium. Comp Biochem Physiol C Toxicol Pharmacol. 2006;144(1):16–24.PubMedGoogle Scholar
  114. 114.
    Ahmad M et al. Effectiveness of zinc in modulating perinatal effects of arsenic on the teratological effects in mice offspring. Biol Res. 2013;46(2):131–8.PubMedGoogle Scholar
  115. 115.
    Milton AG, Zalewski PD, Ratnaike RN. Zinc protects against arsenic-induced apoptosis in a neuronal cell line, measured by DEVD-caspase activity. Biometals. 2004;17(6):707–13.PubMedGoogle Scholar
  116. 116.
    Flora SJ, Pachauri V. Chelation in metal intoxication. Int J Environ Res Public Health. 2010;7(7):2745–88.PubMedCentralPubMedGoogle Scholar
  117. 117.
    Ram Kumar M, Flora SJ, Reddy GR. Monoisoamyl 2,3-dimercaptosuccinic acid attenuates arsenic induced toxicity: behavioral and neurochemical approach. Environ Toxicol Pharmacol. 2013;36(1):231–42.PubMedGoogle Scholar
  118. 118.
    Mondal S et al. Prevention of arsenic-mediated reproductive toxicity in adult female rats by high protein diet. Pharm Biol. 2013;51(11):1363–71.PubMedGoogle Scholar
  119. 119.
    Seow WJ et al. Arsenic reduction in drinking water and improvement in skin lesions: a follow-up study in Bangladesh. Environ Health Perspect. 2012;120(12):1733–8.PubMedCentralPubMedGoogle Scholar

Copyright information

© The Author(s) 2014

Open Access This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.

Authors and Affiliations

  1. 1.Department of NeuroscienceUniversity of New Mexico School of MedicineAlbuquerqueUSA

Personalised recommendations